Oleoylethanolamide (OEA)
Oleoylethanolamide (OEA) is a naturally occurring fatty acid amide that regulates appetite and weight management by activating PPAR-alpha receptors. It promotes satiety, enhances fat oxidation, and helps reduce calorie intake through modulation of gut-brain signaling pathways.

Origin & History
Oleoylethanolamide (OEA) is a lipid mediator derived from oleic acid, commonly found in olive oil. It is produced in the small intestine and can be synthesized for supplements.
Historical & Cultural Context
OEA's role in appetite regulation was discovered in the early 2000s, with its effects being studied for potential weight management solutions.
Health Benefits
- Promotes satiety and aids in weight management by activating PPAR-alpha receptors, leading to reduced calorie intake and increased fat oxidation. - Supports lipid metabolism and fat oxidation, enhancing the body's ability to break down fats for energy. - Regulates appetite by modulating the gut-brain axis, which can lead to a 30% reduction in food intake, according to studies. - Enhances energy expenditure by increasing thermogenesis, helping burn more calories even at rest. - Improves insulin sensitivity, which can lower the risk of type 2 diabetes by up to 20%. - Reduces inflammation through its interaction with the endocannabinoid system, promoting overall metabolic health. - Supports cardiovascular health by lowering LDL cholesterol levels and improving blood lipid profiles.
How It Works
OEA activates peroxisome proliferator-activated receptor alpha (PPAR-α) in the small intestine, triggering the release of satiety hormones and enhancing fatty acid oxidation. It also modulates the vagus nerve and activates GPR119 receptors, sending satiety signals to the hypothalamus. Additionally, OEA increases the expression of fatty acid oxidation enzymes like carnitine palmitoyltransferase I (CPT-1).
Scientific Research
Research includes animal studies and a few human trials, showing its role in appetite regulation and weight management. More RCTs are needed for conclusive evidence.
Clinical Summary
Human studies on OEA supplementation are limited, with most research conducted in animal models. A small pilot study showed 250mg of OEA twice daily reduced body weight by 3.2% over 8 weeks in overweight adults. Animal studies demonstrate significant appetite suppression and weight loss, but larger randomized controlled trials are needed to establish clinical efficacy and optimal dosing in humans.
Nutritional Profile
- Derived from oleic acid, a monounsaturated fat. - Influences the PPAR-alpha receptor involved in fat metabolism. - Non-psychoactive and naturally occurring in the body.
Preparation & Dosage
Typical dosage is 100 mg to 200 mg per day, taken before meals. Consult a healthcare provider before use.
Synergy & Pairings
Green Tea Extract, CLA, L-Carnitine
Safety & Interactions
OEA appears well-tolerated in limited human studies, with no serious adverse effects reported at doses up to 500mg daily. Potential mild side effects may include digestive discomfort or nausea when taken without food. No significant drug interactions have been documented, but OEA may theoretically enhance the effects of weight loss medications. Safety during pregnancy and breastfeeding has not been established, so use should be avoided in these populations.